OKUR (OnKure Therapeutics) Short Interest


OKUR OnKure Therapeutics Inc OKUR
14 GF Score
Price $4.20
! 1 Warning Sign
View Full Analysis

What is OnKure Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OKUR vs PLX, MIST, GALT: Short Interest Comparison

For the Biotechnology subindustry, OnKure Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OnKure Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OnKure Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where OnKure Therapeutics's Short Interest falls into.


OKUR
14GF Score
OnKure Therapeutics Inc OKUR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OnKure Therapeutics Business Description

Address 6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3K?. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
14GF Score

Get the complete analysis for OKUR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.20
Price